Académique Documents
Professionnel Documents
Culture Documents
INTRODUCTION/EPI Milestones
1976 - Launching of EPI
1986 - UCI Goal Acceleration
1989 – Adoption of Wed. as Immunization Day
1992 – integration of Hep B
(target : 40% of 0-11 months old)
INTRODUCTION
Major Strategies
1. Sustaining high routine FIC coverage at least 95% in all provinces and cities
2. Sustaining polio-free country for global eradication ( NIDs- 1993-1996)
3. Eliminating measles by 2008
1998 – catch up campaign (Ligtas Tigdas)
2004- follow-up campaign
2007- 2ND follow-up campaign (KOT)
4. Eliminating neonatal tetanus
5. Control diphtheria,pertusis, Hep B and extra pulmonary TB
April –May 2012 - Iiigta sa Tignas ng Pinas
MR SIA (Measles Rubella Supplemental Activity – Door to Door Strategy to eliminate measles by 2012.
May 21, 2012 Dept. Mmemorandum Administration of Rotavirus Vaccine for Infants in National House Targeting
System
CONCEPT and IMPORTANCE of VACCINATION
IMMUNIZATION – promote health and protect children from disease causing agents
> PASSIVE Immunity
> ACTIVE Immunity
OBJECTIVES OF EPI:
To reduce the morbidity and mortality rates of the following immunizable diseases :
TB,tetanus,diphtheria, pertussis, measles, poliomyelitis, hepatitis B,influenza, rubella, and mumps
1.Active Immunization – antibodies are produced by the body in response to infection
Natural – antibodies are formed in the presence of active infection in the body. It is a lifelong immunity. e.g.
recovery from mumps, chickenpox
Artificial – antigens (vaccines or toxoids) are administered to stimulate antibody production. Requires
booster inoculation after many years. e.g. tetanus toxoid, oral polio vaccine, etc.
Passive Immunization – antibodies are produced by another source such as animal or human
Natural – antibodies are transferred from the mother to her newborn through the placental or in the
colostrums
Artificial –immune serum (antibody) from an animal or another human is injected to a person e.g. tetanus
immunoglobulin human, rabies immunoglobuli
NEW VACCINES
Anti-measles vaccine should be given at least 9-11 months old before MMR will be injected at 12-15months old
.There shall be at 4 weeks interval between measles vaccine-MMR.Anti-Measles vaccine given at 9 -11 months
shall be called AMV 1 and MMR shall be called AMV2
“Rotarix” vaccines rotavirus Immunizatiion – given among infants of families identified to the NHTS provided by the
DSWD)
Given in 2 doses, administered orally to infants the first dose given to age 6 weeks age to 15 weeks
Second dose given to infants age 6 weeks ged 10 weeks up to maximum of 32 weeks.
v
he
Ex
0°C
Cold Room
ICE PACK
FREEZERS
ICE-LINED FREEZER
Modified
Vaccine
Refrigerator
THERMOMETER
HOW TO MONITOR THE REFRIGERATOR TEMPERATURE
TRANSPORT BOX
VACCINE CARRIERS
Side Effects:
1.Koch’s phenomenon- an acute inflammatory reaction appearing within two to four days of vaccination. It
is not serious and disappears rapidly. No management is needed.
2. Deep Abscess at vaccination site/glandular enlargement. – Incision and drainage of the abscess is
necessary. Apply powdered INH.
3.Indolent ulceration – an ulcer, which persists after 12 weeks from, date of vaccination an ulcer more than
10 mm deep. This is due to deep injection or secondary infection. Treat with INH powder.
4.Glandular enlargement – the glands draining the injection site may become enlarged. If suppuration
occurs, treat as deep abscess.
DTP
Side effects:
1.Fever – if fever lasts more than 24 hours after a dose of DTP is not due to the vaccine but to other causes.
Advise mother to give anti-pyretic to the child.
2.Local soreness – pain or swelling in the area where injections was given. If this starts early after the
injection, then it is only due to the vaccine. Reassure mothers that it needs no treatment and will disappear
within 3-4 days
3.Abscess – that appear a week or more after the injection is due to wrong technique, either the vaccine
was not injected deep enough or the needle was not sterile
Incision and drainage is necessary.
4. Convulsions – are very rare and occur more in children about three months of age. This is due to the
Pertussis component of the vaccine.
If this occurs, do not continue the normal course of DTP.
Polio Vaccine
Side effect – usually none
Measles Vaccine
Side effects:
1. Fever, and rash – usually fever after five to seven days from the time of vaccination. Fever may last
from 1-3 days. Sometimes, there is a mild measles rash. Give anti-pyretics.
Reassure the mother and advise her to give antipyretics to the child.
Tetanus Toxoid
Side effects:
1. Pain
2. Redness swelling for a few days at the site of the injection.
Reassure the mother.
No treatment needed
Hepatitis B
Side effects – local soreness; apply warm compress
Rotarix – No serious adverse reaction
“LIGTAS SA TIGDAS ANG PINAS”
A Door-to-Door Measles-Rubella (MR SIA)
Supplemental Immunization Campaign
Eligible Children:
9 months to 95 months old whether the child received measles- containing vaccine
Sa
SANGGOL
at
INA
An essential public health program that prevents catastrophic health consequences from inborn disorders through:
Early detection
Early diagnosis
Early treatment
Positive
Confirmatory Test
Positive
No
Y
E
IT
RA
AS UQ
SU
WHICH DISORDERS ARE SCREENED?
Inborn, but without obvious signs at birth
Significantly prevalent in the population
Life threatening or cause severe mental and physical disability if not detected and treated early
Known cure:
Supplementation
Avoidance
WHICH DISORDERS ARE SCREENED?
In the Philippines:
Congenital Adrenal Hyperplasia (CAH)
21 hydroxylase deficiency
Congenital Hypothyroidism (CH)
Primary Congenital Hypothyroidism
Glucose 6-Phosphate Dehydrogenase (G6PD) deficiency
Galactosemia
Phenylketonuria (PKU)
Cong
Adren
Hyper
Losse
CONGENITAL ADRENAL
HYPERPLASIA
CONGENITAL HYPOTHYROIDISM
SALT LOSSERS
Large Fontanel
Large Tongue
Abdominal Distention
Umbilical Hernia
GOOD Hypo
BABIES
Inac
CRETINISM
Umbilical
Hernia
Disproport
short
Broad nose w/
depressed bridge
GALACTOSEMIA
CLINICAL MANIFESTATIONS Narrow chest w/
Edema curved back
Ascites
Hepatomegaly
Cataracts
Mental retardation
Growth failure
RBC’S UNDERGO HEMOLYSIS WITHOUT G6PD!
No
G6PD
Oxidative
Oxidative
N
substance
substance
ss
TH A
Y OU
K
HEMO